NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
S Peter Wu
New York University - New York / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4688700
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
S Peter Wu's MOST POPULAR ARTICLES
1-)
Treatment with carfilzomib-lenalidomide-dexamethasone with lenalidomide extension in patients with smoldering or newly diagnosed multiple myelomaN Korde, M Roschewski, A Zingone, M Kwok, EE Manasanch, M Bhutani, ...JAMA oncology 1 (6), 746-754, 20153022015
2-)
The IRE1α/XBP1s pathway is essential for the glucose response and protection of β cellsJR Hassler, DL Scheuner, S Wang, J Han, VK Kodali, P Li, J Nguyen, ...PLoS biology 13 (10), e1002277, 20151262015
3-)
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrenceLM Katz, T Hielscher, B Liechty, J Silverman, D Zagzag, R Sen, P Wu, ...Acta neuropathologica 135 (6), 955-963, 2018962018
4-)
Phase II clinical and correlative study of carfilzomib, lenalidomide, and dexamethasone followed by lenalidomide extended dosing (CRD-R) induces high rates of MRD negativity in …N Korde, A Zingone, ML Kwok, EE Manasanch, M Bhutani, N Tageja, ...Blood 122 (21), 538, 2013692013
5-)
Survival of oral tongue squamous cell carcinoma in young adultsJR Oliver, SP Wu, CM Chang, DF Roden, B Wang, KS Hu, D Schreiber, ...Head & neck 41 (9), 2960-2968, 2019552019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept